Glossary of Longevity Science
A comprehensive A-to-Z reference of the terminology used in aging research, peptide science, and longevity medicine—searchable, categorized, and cross-linked.
A comprehensive A-to-Z reference of the terminology used in aging research, peptide science, and longevity medicine—searchable, categorized, and cross-linked.
Compounded drugs are not FDA approved. Category 1 identifies substances nominated for FDA evaluation; it is not drug approval or blanket permission to compound a peptide. Eligibility depends on the substance, circumstances and applicable requirements. FDA category explanation.
BPC-157 acetate: the October 2026 HHS interim peptide-compounding policy addresses this substance subject to conditions. That policy is not FDA drug approval or proof that a treatment is safe and effective. HHS notice · Policy and appendices (PDF).
Selected regulatory definitions updated November 12, 2026. Other glossary entries have not been newly reviewed.
For Educational & Research Purposes Only. Definitions are simplified for accessibility and are not exhaustive. This glossary does not constitute medical advice. Consult the primary literature and a licensed healthcare provider for clinical guidance. Annume Vitality Lab makes no claims regarding the safety, efficacy, or legal status of any compound referenced herein.